Re:Hospitals and universities repurposing drugs at 90% lower...
by VladVladikoff on Thursday June 18, 2026 @10:46PM
(#48594301)
What’s so interesting about this that I just learned after googling about Spravato that ketamine is a treatment for serious depression. Why? That’s fascinating! Is it the dissociative effects?
[ Parent
| on HN ]
Re:Hospitals and universities repurposing drugs at 90% lower...
by kevinoid on Friday June 19, 2026 @12:09PM
(#48600147)
A significant effect is through opioid receptor activation, as demonstrated by Williams et al. <https://doi.org/10.1038/s41380-019-0503-4> by blocking the receptor with naltrexone, which attenuated the antisuicidality effects.
The Huberman Lab episode Ketamine: Benefits and Risks for Depression, PTSD & Neuroplasticity <https://www.hubermanlab.com/episode/ketamine-benefits-and-ri...> and the referenced journal articles (including the above) have a lot of detail on it.
Re:Hospitals and universities repurposing drugs at 90% lower...
by pas on Sunday June 21, 2026 @10:20AM
(#48619218)
we don't know.
https://lorienpsych.com/2021/11/02/ketamine/#11_How_does_ket...
the opiate receptor interaction might be important, but it seems that the antidepressant effect persists even if the opiate pathway is blocked (via naltrexone)
https://pmc.ncbi.nlm.nih.gov/articles/PMC6439824/ (though it's an open-label super small study ... n=4)